- Home
- BBNX vs PAHC Comparison
BBNX vs PAHC Comparison
Compare BBNX & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBNX
- PAHC
- Stock Information
- Founded
- BBNX 2015
- PAHC 1946
- Country
- BBNX United States
- PAHC United States
- Employees
- BBNX N/A
- PAHC N/A
- Industry
- BBNX Medical/Dental Instruments
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- BBNX Health Care
- PAHC Health Care
- Exchange
- BBNX Nasdaq
- PAHC Nasdaq
- Market Cap
- BBNX 973.6M
- PAHC 902.8M
- IPO Year
- BBNX 2025
- PAHC 2014
- Fundamental
- Price
- BBNX $22.87
- PAHC $22.34
- Analyst Decision
- BBNX
- PAHC Sell
- Analyst Count
- BBNX 0
- PAHC 4
- Target Price
- BBNX N/A
- PAHC $20.50
- AVG Volume (30 Days)
- BBNX 2.0M
- PAHC 135.9K
- Earning Date
- BBNX 01-01-0001
- PAHC 02-05-2025
- Dividend Yield
- BBNX N/A
- PAHC 2.15%
- EPS Growth
- BBNX N/A
- PAHC N/A
- EPS
- BBNX N/A
- PAHC 0.43
- Revenue
- BBNX $53,034,000.00
- PAHC $1,046,762,000.00
- Revenue This Year
- BBNX N/A
- PAHC $27.25
- Revenue Next Year
- BBNX N/A
- PAHC $14.13
- P/E Ratio
- BBNX N/A
- PAHC $52.06
- Revenue Growth
- BBNX 6601.12
- PAHC 7.17
- 52 Week Low
- BBNX $21.81
- PAHC $10.04
- 52 Week High
- BBNX $24.50
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- BBNX N/A
- PAHC 59.45
- Support Level
- BBNX N/A
- PAHC $21.05
- Resistance Level
- BBNX N/A
- PAHC $22.31
- Average True Range (ATR)
- BBNX 0.00
- PAHC 0.63
- MACD
- BBNX 0.00
- PAHC 0.15
- Stochastic Oscillator
- BBNX 0.00
- PAHC 93.35
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.